Literature DB >> 32479953

Phosphoglycerate kinase 1 (PGK1) in cancer: A promising target for diagnosis and therapy.

Qi Fu1, Zhenhai Yu2.   

Abstract

Phosphoglycerate kinase 1 (PGK1) is the first critical enzyme to produce ATP in the glycolytic pathway. PGK1 is not only a metabolic enzyme but also a protein kinase, which mediates the tumor growth, migration and invasion through phosphorylation some important substrates. Moreover, PGK1 is associated with poor treatment and prognosis of cancers. This manuscript reviews the structure, functions, post-translational modifications (PTMs) of PGK1 and its relationship with tumors, which demonstrates that PGK1 has indispensable value in the tumor progression. The current review highlights the important role of PGK1 in anticancer treatments.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; Glycolysis; PGK1; Post-translational modifications; Protein kinase

Year:  2020        PMID: 32479953     DOI: 10.1016/j.lfs.2020.117863

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  10 in total

1.  N6-methyladenosine reader YTHDF3 contributes to the aerobic glycolysis of osteosarcoma through stabilizing PGK1 stability.

Authors:  Deyin Liu; Zhong Li; Kun Zhang; Daigang Lu; Dawei Zhou; Yibin Meng
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-28       Impact factor: 4.322

2.  MicroRNA-16-1-3p Represses Breast Tumor Growth and Metastasis by Inhibiting PGK1-Mediated Warburg Effect.

Authors:  Tianxin Ye; Yingchun Liang; Deyu Zhang; Xuewu Zhang
Journal:  Front Cell Dev Biol       Date:  2020-12-03

3.  Positive regulation of PFKFB3 by PIM2 promotes glycolysis and paclitaxel resistance in breast cancer.

Authors:  Chao Lu; Pengyun Qiao; Yonghong Sun; Chune Ren; Zhenhai Yu
Journal:  Clin Transl Med       Date:  2021-04

4.  A Novel Glycolysis-Related Four-mRNA Signature for Predicting the Survival of Patients With Breast Cancer.

Authors:  Xiaolu Zhang; Jia Wang; Jing Zhuang; Cun Liu; Chundi Gao; Huayao Li; Xiaoran Ma; Jie Li; Changgang Sun
Journal:  Front Genet       Date:  2021-01-28       Impact factor: 4.599

5.  Terazosin Stimulates Pgk1 to Remedy Gastrointestinal Disorders.

Authors:  Jingjing Liu; Wenyang Zhao; Chun Li; Tongyu Wu; Liang Han; Zhuozhou Hu; Xiangxiang Li; Jing Zhou; Xinping Chen
Journal:  Int J Mol Sci       Date:  2021-12-30       Impact factor: 5.923

6.  High Expression of Glycolytic Genes in Clinical Glioblastoma Patients Correlates With Lower Survival.

Authors:  Kimberly M Stanke; Carrick Wilson; Srivatsan Kidambi
Journal:  Front Mol Biosci       Date:  2021-12-24

7.  Systematic Analysis Uncovers Associations of PGK1 with Prognosis and Immunological Characteristics in Breast Cancer.

Authors:  Liangdong Li; Yang Bai; Yang Gao; Deheng Li; Lei Chen; Changshuai Zhou; Mingtao Feng; Xin Chen; Wei Jin; Yiqun Cao
Journal:  Dis Markers       Date:  2021-11-08       Impact factor: 3.434

8.  Berberine Attenuates Cell Motility via Inhibiting Inflammation-Mediated Lysyl Hydroxylase-2 and Glycolysis.

Authors:  Yishan Du; Muhammad Khan; Nana Fang; Fang Ma; Hongzhi Du; Zhenya Tan; Hua Wang; Shi Yin; Xiaohui Wei
Journal:  Front Pharmacol       Date:  2022-04-26       Impact factor: 5.988

9.  PGK1 Is a Key Target for Anti-Glycolytic Therapy of Ovarian Cancer: Based on the Comprehensive Analysis of Glycolysis-Related Genes.

Authors:  Rui Gou; Yuexin Hu; Ouxuan Liu; Hui Dong; Lingling Gao; Shuang Wang; Mingjun Zheng; Xiao Li; Bei Lin
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

10.  Prognostic model of invasive ductal carcinoma of the breast based on differentially expressed glycolysis-related genes.

Authors:  Xiaoping Li; Qihe Yu; Jishang Chen; Hui Huang; Zhuangsheng Liu; Chengxing Wang; Yaoming He; Xin Zhang; Weiwen Li; Chao Li; Jinglin Zhao; Wansheng Long
Journal:  PeerJ       Date:  2020-11-04       Impact factor: 2.984

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.